Recombinant Adenovirus (AdV) Type 3 and Type 14 Isolated From a Fatal Case of Pneumonia

Diane C Halstead1, Gregory C Gray, Kenneth S Meyer

  • 1Jacksonville Pathology Consultants, P.A./Baptist Health Infectious Disease Laboratories, Jacksonville, Florida.

Insights

A fatal pneumonia case in a traveler returning from Iraq was linked to a novel adenovirus (AdV) recombinant. Genetic analysis identified a unique AdV3 and AdV14 hybrid, suggesting a new viral strain emerged.

Area of Science:

  • Infectious Diseases
  • Virology
  • Molecular Biology

Background:

  • Adenovirus infections can cause severe respiratory illness, particularly in immunocompromised individuals or travelers.
  • Recent travel history is crucial for identifying potential exposure to novel or endemic pathogens.
  • Coinfections with multiple viral strains can complicate diagnosis and treatment.

Purpose of the Study:

  • To report a fatal case of pneumonia potentially caused by adenovirus infection.
  • To characterize the specific adenovirus strain identified in the patient.
  • To determine if the observed viral characteristics represent a coinfection or a recombinant virus.

Main Methods:

  • Sequence analysis was performed to identify the adenovirus types.
  • Restriction analysis (REA) was utilized to differentiate between coinfection and recombination.
  • Clinical data and patient history were reviewed.

Main Results:

  • The patient, a 53-year-old male, presented with fatal pneumonia after returning from Iraq.
  • Sequence analysis identified both adenovirus type 3 (AdV3) and adenovirus type 14 (AdV14).
  • Restriction analysis indicated the presence of a single recombinant adenovirus with properties of both AdV3 and AdV14, not a coinfection.

Conclusions:

  • A fatal case of pneumonia was associated with a unique adenovirus recombinant.
  • This recombinant adenovirus, a hybrid of AdV3 and AdV14, represents a potentially novel viral entity.
  • Further investigation into the emergence and pathogenicity of adenovirus recombinants is warranted.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...